申请人:ALNYLAM PHARMACEUTICALS, INC.
公开号:US20170233734A1
公开(公告)日:2017-08-17
The present invention relates to lipid nanoparticles containing a biodegradable cationic lipid which provide improved delivery of active pharmaceutical ingredients, such as siRNA.